Mycoplasma Testing Market Is Predicted To Grow Quickly Due To The Increasing Demand For Healthcare Expenditure Levels Till 2025: Grand View Research, Inc.
The global mycoplasma testing market is expected to reach a
value of USD 1.4 billion by 2025, according to a new report by Grand View
Research, Inc. With growing R&D investments in the field of life sciences,
the demand for mycoplasma testing products are anticipated to rise in the near
future. Huge opportunities in the life sciences segment are spurring the market
growth. Hence, a large amount of investment is being made in the biotechnology
and pharmaceutical industries with rising level of healthcare spending across
the globe. This is expected to trigger high growth of mycoplasma testing
market.
Investment in R&D activities
by pharmaceutical and biotechnology companies is increasingly being supported
by the government. Researches involving drug discovery and development, receive
funding from the governmental bodies to a great extent. Moreover, governmental
initiatives in the form of awareness campaigns for chronic diseases such as
cancer are also encouraging research-based activities. Thus, the aforementioned
factors are expected to drive the market growth.
Mycoplasma contamination of cell
culture is a growing concern for most of the research scientists for decades.
Mycoplasma infection arises majorly from laboratory workers as human mycoplasma
contamination occurs at a faster rate. In order to combat further
contamination, mycoplasma tests are being conducted, which is expected to
increase the demand of the related products.
Browse full research report on Mycoplasma Testing Market: http://www.grandviewresearch.com/industry-analysis/mycoplasma-testing-market
Further Key Findings From
the Study Suggest:
- In 2016, kits & reagents dominated the market and
is also expected to show highest CAGR over the forecast period owing to
its wider application in mycoplasma tests
- Amongst the technology segment, Polymerase Chain
Reaction (PCR) held the largest share in 2016 owing to the delivery of
fast & accurate results associated with this technology
- Cell line testing is anticipated to exhibit highest
CAGR over the forecast period due to the increasing risk of cell line
contamination
- In 2016, pharmaceutical and biotechnology companies accounted
for the largest market share due to rising number of research activities
in drug discovery and development
- North America dominated the market in 2016 owing to
rising healthcare spending levels and government funding for life
science-related research
- Some of the key players are Merck KGaA; Sigma-Aldrich
Co.; Thermo Fisher Scientific; Lonza Group Ltd.; Charles River
Laboratories International, Inc.; PromoCell GmbH; and Bionique Testing
Laboratories, Inc.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented
the mycoplasma testing market on the basis of product, technology, application,
end-use, and region:
Mycoplasma Testing Product
Outlook (Revenue, USD Million, 2014 - 2025)
- Instruments
- Kits & Reagents
- PCR Assays
- Nucleic Acid Detection Kits
- Stains
- Elimination Kits
- Standards & Controls
- Others
- Services
Mycoplasma Testing Technology
Outlook (Revenue, USD Million, 2014 - 2025)
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Microbial Culture Techniques
- Enzymatic Methods
Mycoplasma Testing Application
Outlook (Revenue, USD Million, 2014 - 2025)
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Others
Mycoplasma Testing End-Use
Outlook (Revenue, USD Million, 2014 - 2025)
- Academic Research Institutes
- Cell Banks
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Others
Mycoplasma Testing Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- India
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment